16 US CEOs Join Trump in China Seeking Relief From Regulatory Maze

More than a dozen top American chief executives, including Tesla’s Elon Musk and Apple’s Tim Cook, are accompanying President Donald Trump on his May 14-15 visit to China, seeking to resolve pressing business issues with the world’s second-largest economy. The summit with Chinese leader Xi Jinping, the seventh between the two leaders, occurs as companies navigate a complex web of market access restrictions, export controls, and intense regulatory scrutiny.

"Besides Boeing and Cargill being linked to purchase agreements, the others are mainly there to deliver demands on critical input supply," said Reva Goujon, a geopolitical strategist at Rhodium Group. "This could help the US administration's messaging that to even be able to discuss a board of investment, China needs to be a reliable investment partner and not weaponise supply."

The delegation of 16 executives represents a broad cross-section of American industry, from finance giants like BlackRock and Goldman Sachs to technology leaders Meta and Qualcomm. For Mastercard and Visa, the goal is to deepen their footprint in China's tightly controlled payments market. For Tesla, it's about securing approval for its Full Self-Driving system and navigating potential curbs on solar manufacturing equipment exports from China.

For investors, the summit’s significance lies in its potential to improve predictability in a relationship defined by economic competition. Markets are not pricing in a full reset but are watching for any signs of de-escalation in technology policy and trade. The continuity of dialogue itself is seen as a positive, as interruptions tend to amplify volatility across equities, currencies, and credit markets.

A History of 6 Previous Encounters

The Trump-Xi relationship has been a focal point for global markets since their first meeting in April 2017. That initial summit at Mar-a-Lago, intended to build personal rapport, was overshadowed by US airstrikes on Syria. Subsequent meetings on the sidelines of G20 summits in 2017 and 2018 were dominated by North Korea and the burgeoning trade war.

A state visit to Beijing in November 2017 produced $250 billion in announced business deals, though many were non-binding. Despite the positive tone, the Trump administration imposed tariffs on $250 billion of Chinese goods months later. A "phase one" trade deal was eventually signed after their June 2019 meeting in Osaka, but China did not meet its purchase commitments amid the global pandemic. Their most recent meeting before this week was in October 2025 in South Korea, which resulted in a one-year truce in a spiraling tariff war.

Investors Seek Stability Over Breakthroughs

Financial markets are approaching the Beijing talks with a clear hierarchy of expectations, focusing on risk containment rather than a comprehensive breakthrough. According to analysis from Nigel Green of deVere Group, investors are primarily looking for five outcomes: containment of escalation risk, clearer boundaries on technology policy, stable signaling on Taiwan, predictable agricultural trade flows, and a commitment to continued dialogue.

Technology policy remains a central variable. US restrictions on semiconductor and AI development, coupled with Chinese export controls on critical minerals like indium, have shaped global investment. Any indication of stabilization would be supportive for risk assets. Similarly, while a farm deal may be reached to expand Beijing’s purchases of grains and meat, market watchers do not expect major new soybean purchases beyond existing agreements. The key takeaway for investors is the trajectory of engagement; even incremental shifts in tone can have outsized effects on global risk assets.

Several companies face specific, high-stakes challenges. Meta is tackling a Chinese order to unwind its $2 billion acquisition of AI startup Manus. A consortium led by BlackRock faces scrutiny over its planned $23 billion acquisition of ports from CK Hutchison. Meanwhile, Citigroup is still awaiting approval for a wholly owned securities brokerage license after exiting a previous joint venture.

This article is for informational purposes only and does not constitute investment advice.